2021
DOI: 10.1101/2021.12.23.21268305
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

The HUNT Study: a population-based cohort for genetic research

Abstract: The Trøndelag Health Study (HUNT) is a population-based cohort of ~229,000 individuals recruited in four waves beginning in 1984 in Trøndelag County, Norway. ~88,000 of these individuals have available genetic data from array genotyping. HUNT participants were recruited during 4 community-based recruitment waves and provided information on health-related behaviors, self-reported diagnoses, family history of disease, and underwent physical examinations. Linkage via the Norwegian personal identification number i… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5
3

Relationship

8
0

Authors

Journals

citations
Cited by 17 publications
(19 citation statements)
references
References 56 publications
(43 reference statements)
0
19
0
Order By: Relevance
“…We aimed to understand the genetic architectural of sclerostin and the causal role of sclerostin inhibition on atherosclerosis related diseases and risk factors. First, we conducted a GWAS meta-analysis and post-GWAS follow-up analyses of circulating sclerostin in 33,961 European individuals, which including nine cohorts: the Avon Longitudinal Study of Parents and Children (ALSPAC), Die Deutsche Diabetes Dialyse Study (4D), The Gothenburg Osteoporosis and Obesity Determinants (GOOD), and the MANOLIS cohort, Fenland( 19 ), INTERVAL( 20 ), Trøndelag health study (HUNT)( 21 )( 22 )( 23 ), the Osteoarthritis Initiative (OAI)( 24 )( 25 )( 26 )( 27 ), the Ludwigshafen Risk and Cardiovascular Health (LURIC)( 28 )( 29 ). The cohort details were included in Supplementary Note 1 .…”
Section: Resultsmentioning
confidence: 99%
“…We aimed to understand the genetic architectural of sclerostin and the causal role of sclerostin inhibition on atherosclerosis related diseases and risk factors. First, we conducted a GWAS meta-analysis and post-GWAS follow-up analyses of circulating sclerostin in 33,961 European individuals, which including nine cohorts: the Avon Longitudinal Study of Parents and Children (ALSPAC), Die Deutsche Diabetes Dialyse Study (4D), The Gothenburg Osteoporosis and Obesity Determinants (GOOD), and the MANOLIS cohort, Fenland( 19 ), INTERVAL( 20 ), Trøndelag health study (HUNT)( 21 )( 22 )( 23 ), the Osteoarthritis Initiative (OAI)( 24 )( 25 )( 26 )( 27 ), the Ludwigshafen Risk and Cardiovascular Health (LURIC)( 28 )( 29 ). The cohort details were included in Supplementary Note 1 .…”
Section: Resultsmentioning
confidence: 99%
“…Sensitivity analysis. We used the Nord-Trøndelag Health Study (HUNT) 60,61 62,63 . The current analysis includes genetic data from ~90% (N = 71,860) of participants from HUNT2 and HUNT3 who were genotyped by genome-wide SNP arrays in 2015 60,64 .…”
Section: Statistical Analysesmentioning
confidence: 99%
“…We used the Nord-Trøndelag Health Study (HUNT) 60,61 62,63 . The current analysis includes genetic data from ~90% (N = 71,860) of participants from HUNT2 and HUNT3 who were genotyped by genome-wide SNP arrays in 2015 60,64 . For the replication of Alzheimer's disease PRS-outcome associations in the HUNT study, we followed up 33 outcomes (i.e., those variables available in HUNT with sufficient sample numbers for replication) that were associated with the AD PRS in UK Biobank.…”
Section: Statistical Analysesmentioning
confidence: 99%
“…HUNT (Krokstad et al, 2013) is a population-based dataset with longitudinal hospital registries linked to the whole genome data (Brumpton et al, 2021). For the PRS prediction in HUNT, we defined IS with ICD9-codes 434 and 436, and ICD10-codes I63 and I64, resulting in 4,256 ischemic stroke cases (285 prevalent, 3,971 incident, 62,375 non-cases).…”
Section: Star Methodsmentioning
confidence: 99%